1919 Investment Counsel’s GSK GSK Stock Holding History

1919 Investment Counsel’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.1M	Sell	19,169 -937	-5%	-$57.4K	0.02%	376
2014 Q2	$1.34M	Buy	20,106 +1,848	+10%	+$125K	0.03%	356
2014 Q1	$1.22M	Buy	18,258 +1,052	+6%	+$71.1K	0.02%	360
2013 Q4	$1.15M	Sell	17,206 -412	-2%	-$26.7K	0.02%	363
2013 Q3	$1.1M	Hold	17,618	–	–	0.02%	362
2013 Q2	$1.1M	Buy	+17,618	New	+$1.12M	0.03%	355

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1919 Investment Counsel's GSK Position: Q3 2014 in Review

1919 Investment Counsel reduced its GSK (GSK) stake by 4.7% in Q3 2014, selling an estimated $57.4K and leaving 19,169 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #376.

1919 Investment Counsel first reported a position in GSK in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.34M in Q2 2014. 702 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

1919 Investment Counsel held 19,169 shares of GSK worth $1.1M as of Q3 2014.
1919 Investment Counsel sold 937 GSK shares in Q3 2014, an estimated $57.4K.
GSK made up 0.02% of 1919 Investment Counsel's portfolio in Q3 2014, its #376 holding.
1919 Investment Counsel first reported a position in GSK in Q2 2013 and has held it in 6 quarters since.
1919 Investment Counsel's GSK position peaked at $1.34M in Q2 2014.
702 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.